MedPath

Do Oral Contraceptives Protect Against ACL Injuries in Female Athletes

Phase 4
Completed
Conditions
Ligament Injury
Interventions
Drug: Oral Contraceptive Pill, norethindrn a-e estradiol-iron
Registration Number
NCT04899778
Lead Sponsor
Cedars-Sinai Medical Center
Brief Summary

The purpose of this research study is to examine the impact of one type of commonly used birth control pill on blood levels of relaxin and measure changes in knee movement to determine whether there are changes in joint instability (indicating the knee is less stable) that may predispose female athletes to injury. Women not on hormonal birth control will also be enrolled to analyze differences between athletes on and not on birth control and to evaluate typical relaxin levels and knee laxity when birth control pills are not used.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
73
Inclusion Criteria
  • Female
  • 18 years of age or older
  • Currently playing basketball, soccer, or volleyball at Loyola Marymount or Pepperdine
  • If not currently on COC, regular menstrual cycle occurring every 21-35 days
Exclusion Criteria
  • Previous ACL injury
  • Underlying neuromuscular disease
  • Medical contraindication to COC use
  • History of pregnancy
  • Desire to conceive in the next year

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Oral Contraceptive PillOral Contraceptive Pill, norethindrn a-e estradiol-ironOral contraceptive, 1/day, for one year
Primary Outcome Measures
NameTimeMethod
Injuryover the course of 1 year

Any injury resulting in time away from practice or competition

Secondary Outcome Measures
NameTimeMethod
Hip Rotation During a Single-legged Dropbaseline, 4 month visit

Hip flexion, adduction, and internal/external and coronal plane rotation of the knee measured during a singled-legged drop using motion tracking equipment.

Knee Rotation During a Single-legged Dropbaseline, 4 month visit

Hip flexion, adduction, and internal/external and coronal plane rotation of the knee measured during a singled-legged drop using motion tracking equipment.

Joint Hypermobilitybaseline, 4 month visit

Beighton score will be used to assess overall joint laxity. The Beighton score is on a nine-point scale that is based on 5 joint maneuvers. The maximum score is 9, which indicates increased laxity in the joints. A score of zero indicates inflexible joints.

Serum Relaxin Levelbaseline, 4 month visit

level of relaxin measured in each subject

Anterior Knee Laxitybaseline, 4 month visit

Anterior Knee laxity will be evaluated using the KT-2000 and measured in millimeters of anterior translation of the tibia relative to the femur

Trial Locations

Locations (1)

Cedars Sinai Medical Center

🇺🇸

Los Angeles, California, United States

Cedars Sinai Medical Center
🇺🇸Los Angeles, California, United States
Natasha Trentacosta, MD
Contact
310-829-2663
natasha.trentacosta@cshs.org
Melodie Metzger, PhD
Contact
3104237765
Melodie.Metzger@cshs.org
© Copyright 2025. All Rights Reserved by MedPath